| Zeit | Aktuelle Nachrichten von Pharma Bus Review |
|---|
| 10:43 | Corgenix partners with Eli Lilly to develop diagnostic technology |
| 09:43 | Biogen Idec seeks FDA approval for Plegridy in multiple sclerosis therapy |
| 09:43 | Grifols, Aradigm sign licensing deal for inhaled ciprofloxacin formulations |
| 08:43 | GSK, US HHS team up to develop drugs against antibiotic resistance and bioterrorism |
| 08:43 | Jennerex completes enrollment in Phase 2b trial of liver cancer drug |
| 08:43 | Liquidia extends collaboration with PATH to develop Pneumococcal vaccine |
| 08:43 | rlc | packaging expands Poznan pharmaceutical packaging center |
| 22.05. | US Organic Group develops over-the-counter organic anti-itch ointment |
| 22.05. | Avion unveils Prenate Chewable prenatal vitamin |
| 22.05. | Valeant inaugurates international headquarters in Laval |
| 22.05. | InVite Health unveils food-based dietary supplement powder |
| 22.05. | Sanofi, Regeneron announce positive Phase 2a study results of asthma drug |
| 22.05. | GSK to shut down tablet-packaging facility in Melbourne |
| 21.05. | AbbVie begins atrasentan Phase 3 diabetic nephropathy study |
| 21.05. | Steribeam announces results of 6 logs sterilization of B. pumilus spores on standard equipment |
| 21.05. | BASF, Dyadic enter into non-exclusive research, license agreement |
| 21.05. | R-Tech begins enrolling patients in Phase I/II severe dry eye study |
| 21.05. | Acorda obtains additional US patent for ampyra |
| 21.05. | Elsevier, Illumina collaborate to launch Genomics Data app |
| 21.05. | Pfizer discontinues Phase 3 non-hodgkin lymphoma study of inotuzumab ozogamicin |
| 20.05. | Impax introduces authorized generic of Zomig in US |
| 20.05. | Cellular enrolls 50% patients in Phase I knee osteoarthritis trial |
| 20.05. | ImmunoCellular obtains US patent covering use of interleukin 13-receptor alpha 2 protein |
| 20.05. | DBV, Stallergenes sign strategic research partnership targeting respiratory allergies |
| 20.05. | RuiYi, Genor sign RYI-008 development deal in China |
